Summary
Information about intracellular metabolites and pH can be obtained directly and non-invasively from human tissues in vivo by using 31P magnetic resonance spectroscopy. These data can be used in the diagnosis of inherited metabolic conditions which result in abnormal cellular energetics. Defects in the glycogenolytic, glycolytic and oxidative phosphorylation pathways, and other types of disorders, lead to abnormalities identifiable in the magnetic resonance spectra. Because the overall response of the tissue to the basic biochemical abnormality is observed, magnetic resonance spectroscopy should prove to be particularly valuable in the identification and study of new and unusual disorders not easily diagnosed by other methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Radda GK (1986) The use of NMR spectroscopy for the understanding of disease. Science 233: 640–645
Radda GK, Bore PJ, Rajagopalan B (1984) Clinical aspects of 37P NMR spectroscopy. Br Med Bull 40: 155–159
Radda GK, Rajagopalan B, Taylor DJ (1989) Biochemistry in vivo: an appraisal of clinical magnetic resonance spectroscopy. Magn Reson Quart 5: 122–151
Radda GK, Taylor DJ (1985) Applications of nuclear magnetic resonance spectroscopy in pathology. Int Rev Exp Pathol 27: 1–58
Bottomley PA (1989) Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 170: 1–15
Arnold DL, Tylor DJ, Radda GK (1985) Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 18: 189–196
Taylor DJ, Brosnan MJ, Arnold DL, Bore PJ, Styles P, Walton J, Radda GK (1989) Ca’-+-ATPase deficiency in a patient with an exertional muscle pain syndrome. J Neurol Neurosurg Psychol 51: 1425–1433
Oberhaensli RD, Rajagopalan B, Taylor DJ, Radda GK, Collins J, Leonard JV (1988) Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by 31P magnetic resonance spectroscopy. Pediatr Res 23: 375–380
Oberhaensli RD, Rajagopalan B, Taylor DJ, Radda GK, Collins JE, Leonard JV, Schwartz H, Herschkowitz N (1987) Study of hereditary fructose intolerance using 31P magnetic resonance spectroscopy. Lancet 2: 931–934
Oberhaensli RD, Rajagopalan B, Taylor DJ, Collins J, Leonard JV, Radda GK (1987) Study of inborn errors of carbohydrate metabolism by 31-phosphorus magnetic resonance spectroscopy (31P MRS). Eur J Clin Invest 17: A48
Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconer-Smith J (1981) Examination of a case of suspected McArdle’s syndrome by 31P NMR. N Engl J Med 304: 1338–1342
Argov Z, Bank WJ, Maris J, Chance B (1987) Muscle energy metabolism in McArdle’s syndrome by in vivo phosphorus magnetic resonance spectroscopy. Neurology 37: 1720–1724
Argov Z, Bank WJ, Maris J, Leigh JS, Chance B (1987) Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy. Ann Neurol 22: 46–51
Taylor DJ, Bore PJ, Styles P, Gadian DG, Radda GK (1983) Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med 1: 77–94
Argov Z, Bank WJ, Boden B, Ro YI, Chance B (1987) Muscle 31P-NMR in partial glycolytic block: in vivo study of phosphoglycerate mutase deficient patient. Arch Neurol 44: 614–617
Lewis SF, Haller RG, Cook JD, Nunnally RL (1985) Muscle fatigue in McArdle’s disease studied by 31P-NMR: effect of glucose infusion. J Appl Physiol 59: 1991–1994
Edwards RHT, Dawson MJ, Wilkie DR, Gordon RE, Shaw D (1982) Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet 1: 725–731
Frostick SP, Taylor DJ, Dolecki M, Radda GK (1987) 31-Phosphorus MRS studies of denervation and reinnervation of the anterior deltoid. In: Book of abstracts of the 6th annual meeting, Society of Magnetic Resonance in Medicine. Society of Magnetic Resonance in Medicine, Berkeley, California, p 575
Griffiths RD, Cady EB, Edwards RHT, Wilkie DR (1985) Muscle energy metabolism in Duchenne dystrophy studied by 31P NMR: controlled trials show no effect of allopurinol or ribose. Muscle Nerve 8: 760–767
Newman RJ, Bore PJ, Chan L, Gadian DG, Styles P, Taylor DJ, Radda GK (1982) Nuclear magnetic resonance studies of forearm muscle in patients with Duchenne dystrophy. Br Med J 284: 1072–1074
Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B (1987) 37P NMR changes in Duchenne muscular dystrophy: age related metabolic changes. Neurology 37: 165–169
Chance B, Leigh JS, Smith DS, Nioka S, Clark BJ (1986) Phosphorus magnetic resonance studies of the role of mitochondria in the disease process. Ann NY Acad Sci 488: 140–153
Argov Z, Bank WJ, Maris J, Peterson P, Chance B (1987) Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 37: 257–262
Taylor DJ, Styles P, Matthews PM, Arnold DL, Gadian DG, Radda GK (1986) Energetics of human muscle: exercise-induced ATP depletion. Magn Reson Med 3: 44–54
Arnold DL, Matthews PM, Radda GK (1984) Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med 1: 307–315
Radda GK, Bore PJ, Gadian D, Ross BD, Styles P, Taylor DJ, Morgan-Hughes J (1982) 31-P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature 295: 608–609
Hayes DJ, Hilton-Jones D, Arnold DL, Galloway GJ, Styles P, Duncan J, Radda GK (1985) A mitochondria) encephalomyopathy. A combined 31P magnetic resonance and biochemical investigation. J Neurol Sci 71: 283–290
Hayes DJ, Taylor DJ, Bore PJ, Hilton-Jones D, Arnold DL, Squier MV, Gent AE, Radda GK (1987) An unusual metabolic myopathy: a malate-aspartate shuttle defect. J Neurol Sci 82: 27–39
Eleff S, Kennaway NG, Buist NRM, Darley-Usmar VM, Capaldi RA, Bank WJ, Chance B (1984)’ÚP-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 81: 3529–3533
Argov Z, Maris J, Fishbeck K, Bank W, Chance B (1985) In vivo study of lipid myopathies by ‘1P magnetic resonance imaging. Ann Neurol 18: 119–120
Rajagopalan B, Brindle KM, Harington RM, Oberhaensli R, Pippard MJ, Weatherall DJ, Radda GK (1988) An investigation into the nature of intracellular iron in iron overload. Clin Sci 74 [Suppl 18]: 60 P
Gadian DG, Radda GK, Ross BD, Hockaday J, Bore P, Taylor D, Styles P (1981) Examination of a myopathy by nuclear magnetic resonance. Lancet 2: 774–775
Duboc D, Jehenson P, Tran Dinh S, Marsac C, Syrota A, Fardeau M (1987) Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology (NY) 37: 663–671
Chance B, Eleff S, Bank W, Leigh JS Jr, Warnell R (1982) 31P NMR studies of control of mitochondria] function in phosphofructokinase-deficient human skeletal muscle. Proc Natl Acad Sci USA 79: 7714–7718
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Taylor, D.J. (1990). Magnetic Resonance Spectroscopy. In: Fernandes, J., Saudubray, JM., Tada, K. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02613-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-02613-7_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-02615-1
Online ISBN: 978-3-662-02613-7
eBook Packages: Springer Book Archive